Osteoporosis after spinal cord injury.
Osteoporosis is a known consequence of spinal cord injury (SCI) and occurs in almost every SCI patient. It manifests itself as an increase in the incidence of lower extremity fractures. The pattern of bone loss seen in SCI patients is different from that usually encountered with endocrine disorders and disuse osteoporosis. In general, there is no demineralization in supralesional areas following SCI. Several factors appear to have a major influence on bone mass in SCI individuals, such as the degree of the injury, muscle spasticity, age, sex and duration after injury. At the lumbar spine, bone demineralization remains relatively low compared to that of the long bones in the sublesional area. A new steady state level between bone resorption and formation is reestablished about 2 years after SCI. SCI may not only cause bone loss, but also alter bone structure and microstructure. Trabecular bone is more affected than cortical bone in the SCI population. Numerous clinical series have reported a high incidence ranging from 1 to 34% of lower extremity fractures in SCI patients. The pathogenesis of osteoporosis after SCI remains complex and perplexing. Disuse may play an important role in the pathogenesis of osteoporosis, but neural factors also appear to be important. SCI also leads to impaired calcium and phosphate metabolism and the parathyroid hormone (PTH)-vitamin D axis. Pharmacologic intervention for osteoporosis after SCI includes calcium, phosphate, vitamin D, calcitonin and biphosphonates. However, the concomitant prescription of bone-active drugs for the prevention and treatment of osteoporosis remains low, despite the availability of effective therapies. Functional stimulated exercises may contribute to the prevention of bone loss to some extent. In addition, many unanswered questions remain about the pathogenesis of osteoporosis and its clinical management.
Jiang
Sheng-Dan
SD
Department of Orthopedic Surgery, Xinhua Hospital of the Shanghai Second Medical University, 1665 Kongjiang Road, 200092, Shanghai, China.
Dai
Li-Yang
LY
Jiang
Lei-Sheng
LS
D000375:Aging / Q000502:physiology; D015519:Bone Density / Q000502:physiology; D001862:Bone Resorption / Q000503:physiopathology; D002118:Calcium / Q000378:metabolism; D005081:Exercise Therapy / Q000379:methods; D005260:Female; D050723:Fractures, Bone / Q000209:etiology / Q000503:physiopathology; D006706:Homeostasis / Q000502:physiology; D006801:Humans; D008297:Male; D010024:Osteoporosis / Q000209:etiology* / Q000503:physiopathology / Q000628:therapy; D010264:Paraplegia / Q000209:etiology / Q000503:physiopathology; D010281:Parathyroid Hormone / Q000378:metabolism; D010710:Phosphates / Q000097:blood; D015398:Signal Transduction / Q000502:physiology; D013119:Spinal Cord Injuries / Q000150:complications* / Q000503:physiopathology / Q000628:therapy; D013314:Stress, Mechanical; D014807:Vitamin D / Q000378:metabolism
D010281:Parathyroid Hormone; D010710:Phosphates; D014807:Vitamin D; D002118:Calcium